Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × denileukin diftitox × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Completed 3 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 30 Radiotherapy 21 Cisplatin 20 fludarabine 19 Paclitaxel 17 Nivolumab 16 Magnetic Resonance Spectroscopy 16 fludarabine phosphate 14 Carboplatin 14 pembrolizumab 13 Specimen Handling 13 Gemcitabine 13 Radiation 11 Biopsy 11 Docetaxel 10 Melphalan 9 Filgrastim 9 Etoposide 9 Dexamethasone 9 Cytarabine 9 Radiosurgery 8 Granulocyte Colony-Stimulating Factor 8 Doxorubicin 8 venetoclax 7 trametinib 7 durvalumab 7 Sorafenib 7 Rituximab 7 Pemetrexed 7 Ipilimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00224354 2012-05-21

CLONTAK

Baylor College of Medicine

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡